0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Neurology | 
Viewpoint |  ONLINE FIRST
Carmen Kut, BS; Stuart A. Grossman, MD; Jaishri Blakeley, MD
JAMA Neurol. Published online February 02, 2015. doi:10.1001/jamaneurol.2014.3736

JAMA Internal Medicine | 
Invited Commentary | 
Nancy A. Rigotti, MD
JAMA Intern Med. 2015;175(2):272-273. doi:10.1001/jamainternmed.2014.6921.

JAMA Internal Medicine | 
Original Investigation | 
Peter Hajek, PhD; Hayden McRobbie, MB, ChB, PhD; Katherine Myers Smith, DPsych; et al.
JAMA Intern Med. 2015;175(2):266-271. doi:10.1001/jamainternmed.2014.6916.
Includes: Supplemental Content

JAMA Ophthalmology | 
Original Investigation |  ONLINE FIRST
Mingwei Zhao, MD; Feng Zhang, MD; Youxin Chen, MD; et al.
JAMA Ophthalmol. Published online January 02, 2015. doi:10.1001/jamaophthalmol.2014.5312
Includes: Supplemental Content

JAMA | 
Editorial | 
Peter M. Nilsson, MD, PhD; Fredrik H. Nystrom, MD, PhD
JAMA. 2014;312(8):795-796. doi:10.1001/jama.2014.10058.

JAMA | 
Original Investigation |  FREE
Richard J. McManus, FRCGP; Jonathan Mant, MD; M. Sayeed Haque, PhD; et al.
JAMA. 2014;312(8):799-808. doi:10.1001/jama.2014.10057.
Includes: Supplemental Content

JAMA Internal Medicine | 
Invited Commentary | 
Dhruv S. Kazi, MD, MSc, MS; Mark A. Hlatky, MD
JAMA Intern Med. 2014;174(8):1338-1339. doi:10.1001/jamainternmed.2014.1227.

JAMA Internal Medicine | 
Original Investigation | 
Kathleen Stergiopoulos, MD, PhD; David L. Brown, MD
JAMA Intern Med. 2014;174(8):1330-1338. doi:10.1001/jamainternmed.2014.2368.
Includes: Supplemental Content

JAMA Ophthalmology | 
Original Investigation | 
Michael V. Boland, MD, PhD; Dolly S. Chang, MD, PhD; Travis Frazier, MD; et al.
JAMA Ophthalmol. 2014;132(7):845-850. doi:10.1001/jamaophthalmol.2014.857.
Includes: Supplemental Content

JAMA | 
Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(24):2473. doi:10.1001/jama.2014.7063.

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Viewpoint  | 
How Critical Is the Blood-Brain Barrier to the Development of Neurotherapeutics?
Carmen Kut, BS; Stuart A. Grossman, MD; Jaishri Blakeley, MD
JAMA Internal Medicine
Invited Commentary  | 
Improving the Success of Treating Tobacco Smokers
Nancy A. Rigotti, MD
JAMA Internal Medicine
Original Investigation  | 
Increasing Varenicline Dose in Smokers Who Do Not Respond to the Standard Dosage:  A Randomized Clinical Trial
Peter Hajek, PhD; Hayden McRobbie, MB, ChB, PhD; Katherine Myers Smith, DPsych; et al.
JAMA Ophthalmology
Original Investigation  | 
A 50% vs 30% Dose of Verteporfin (Photodynamic Therapy) for Acute Central Serous Chorioretinopathy:  One-Year Results of a Randomized Clinical Trial
Mingwei Zhao, MD; Feng Zhang, MD; Youxin Chen, MD; et al.